CD274 and non-small cell lung carcinoma: Patients who receive definitive IMPT re-irradiation for NSCLC and SCLC can experience prolonged disease control with limited toxicity or detriment to quality of life, particularly in the modern era with regular use of PD-L1 immune checkpoint inhibitors.